U.S. News
• PDUFA Funding (1992 Act): Acts as the initial input line, where fast-track "user fees" paid directly by pharmaceutical corporations pump private capital into the federal government's regulatory machinery, the FDA, which in turn, processes drug assessments where public safety mandates are disregarded with Corporate Pharmaceutical companies pay-for-FDA-review qualification. This happenstance business happens while another conflict-of-interest, and openly documented is perpetuated: the Revolving Door between the FDA & Corporate Pharmaceutical companies: a continuous feedback loop recycling personnel, where a significant percentage of regulatory reviewers routinely exit the agency to accept lucrative consulting or executive positions within the industry they just regulated. As such, mainstream journals (NEJM & The Lancet); the primary exhaust system responsible for filtering & distributing raw research outputs to the public, currently face severe internal friction over corporate data distortion and the active suppression of clinical trial failures. Hence, real scientific research is censored & is blocked from opposing the business practice of the pharmaceutical industry, which according to the McCullough Foundation & Florida's Surgeon General, Joseph Ladapo, is creating massive death & physiological injury in millions of people worldwide.
Send this to someone
A civic square for verified Americans, open to the nations of the world, its leaders & ambassadors. Reading is open to everybody. Posting, replying and voting are for members.